                           ˿µϣ20130531գ

13.05.26-30ûи
13.05.31, ӡǲǽʳƷ
13.05.31, ӡѧʦҡ¡
13.05.31, ֱ䣺ӽƷҵ
13.05.31, ΢̸̸Ф
13.05.31, ӡӪרҡĵ֪ԡ
13.05.31, ѡһһӡˢ
13.05.31, formergskemployeesGSKзܲòؾNature Medicineٶ·ְ
13.05.31, 鰮ߡ䷢µһЩʡ
13.05.31, ٱйԺԺʿѡ˳
13.05.31, Բ֮
13.05.31, ٽںûί
13.05.31, ɳ廪ʦͨԵĺ
13.05.31, йоԺԬءӳϮ
13.05.31, մѧѧѧѧԺڡѵմѧϢϵĵطһĵļ
13.05.31, ʸФԳƵĳɹˮˡ
13.05.31, ЩΪԭױƷվ̨йڡר˴
13.05.31, Զҽҩҽ롰ֵֻ֧֮⡰о
13.05.31, Ĳݹȥ30ǧ ޶Ч

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

                    ǲǽʳƷ

                        ӡ

йǴ󶹵Ĺ磬ǴСͳԶƤȵȸָ
ƷѷƷ඼ݳƷͨй˲
䵰ʵҪԴңʳĵԴҪԵ
ƷȶʳƷȻ󶹲һй
ģǾ󲿷ֶϺեֱͣӹʳõĺ١

ӶʳƷ뵰ʵһǣҪͬʱܶ౥֬ᣬ
˻ѪܼķաѪܼʾӸ߲µԭ򱻹ڶ
֬࣬ڶʳƷ࣬ҽѧᳫҲ
ѴƷΪʳʵҪԴ1999꣬ʳƷҩƷ
ڶƷϡ󶹵ʿܼಡաΪͱ
֬͵͵̴ʳһ֣ÿ25˴󶹵ʿܼಡա
ıʶӴ˴ɽʳƷЩ׷󽡿ԳԶƷΪʱ֣
ԽΪĿȫԶʳƷʳߡʱ
ǿֶٵͳýֶͳΪ˽ÿԶTofukung 
fuһýϳƵߵԺĴʻ㡣

ΪƷܹȡʳƷΪΪ󶹵ʵƷʺͶ
һá嵰ʵİ20֣11
лϳɵģһҪʳգʣµ9ְ
޷ԼϳɵģʳﵰգΪ谱ᡣʳﵰ
Ʒʵĺûȡ谱Ậͱ1990꣬Ϲũ֯
֯һµķʳﵰʵƷʣΪУ
PDCAAS߷Ϊ1󶹵ʵĵ÷0.91÷
Ϊ1ļסţҵ׺嵰൱˺ܶ˰Ѵ󶹵׵뼦
סţ̵һʵĵס

ʵϴ󶹵ȻҲʵףȴʵġ󶹵׵
Ҫȱȱ谱ᣨҲеᣩ京ȶﵰ٣
ȹ൰Ҳ١ΪˣôҪӺϳɵļᣬ
ҪΪһ껨1ԪʳõĶƷеҲ
˼ǿ󶹵һֱ谱ĺȹ൰׸ߣ
˵ӪģڴͼӹУת
ûõʣʧһ֣󶹵ʵҲȱᡣ
ĿǰоͨתӴ󶹵еļ
ĺͼһݵô󶹵׸ʡ⣬Դ󶹵׵ʱ
ϲ󶹵ɰᱻպ󣬺ܿתųԺϳ
ڵʵЧʱȲţ̵ס

    PDCAAS۷ȱݣϹũ֯һֽп
ȱDIAAS·۵ʵƷʡַţ̵
׵ĵ÷ֱȴ󶹵׸10%30%磬󶹷뵰Ϊ1Ũ嵰Ϊ
1.10뵰Ϊ1.25Ũţ̵Ϊ1.31

ǰΪ󶹵׿ȡ嵰ףӤ䷽̷еĵ
еõľǴ󶹵סǸ2001һƪģԴ󶹵䷽Ӥ
嵰䷽Ӥȣ󽡿״в죬ǰ߸׵͹
2008꣬ЭὨ飬ҽѧҪӤǲ
֢ӤҪ䷽̷۵Ļֻܳ嵰䷽ġһЩҲƵ
涨

һĻɫɫʽдͪһЩΪжֱ
ЧԤѪܼԤ֢ӻ˥ϵȵȣгϻԴ
ͪΪҪɷֵıƷʵЩЧֻг֤ݣ
֤ݣδõȷֵ֤עǣͪһֲƼأ
ڴƼϣ΢ĴƼػԣпܶ״
Ӱ졣2008ѧѧԺҽѧԺĵ鷢֣붹Ʒ϶
ˣϵ͡ʵͪӰԶԹ
ܡоԱй˲ϰ˸ߵԭΪ
˳̫ĶƷҲСģٴʳеĴ
ͪŮԻǴͪĺȻǲݺӵġ2008
һи60ӳص鷿ʴ֢
Ƽغֵ4һֱҲҽ˽⵽ÿ3
3̵ϰߣΪͪģҪٺ
ˣڴƼغָ

ʳԭʳ⣬ʳʹͬһӪصԴҲӦ
þĳʳﵱɡʳƷһءȡ
ֻʵ䷴

2013.5.29

»ÿյѶ2013.5.31

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

               ѧʦҡ¡

                          ӡ

ѧʦһСʱǰһ΢Ϊһǰ
¡ѧʦҡ¡ĻӦ

@ ֪ 48,900 壿ƳдʫҲҶ
ʫֻʫסˣ޷Ҷôùùң
˳һףҹ߾¥˪¿ģһװǽ
ѩ˵Ƴ£׵ʱԼʫɣѧ
ˡ

Ƴдʫ48900ףȫʵ48900ǿ
ʵڸȫʫдʱ˵ģʫ48900ף2300ˡ
ۣߣûȫʫܹ¼˶ʫձѧƽ
һͳƹֿʵˣʵȫʫܹ¼ʫ
49403סһЩִʫȫʫ©յġѧо
1992桶ȫʫࡷ¼ȫʫ©յʫ6809סִ
ʫ56212סԺ½һЩʫȻҲǾ
ƳдʫΪԶ׼Ƴдʫʫ϶Ǵ󲿷
ûġƳ289ƣƽһȫʫ200ףƽ
һȫʫ1ףǻܳƵʫ

ʦﷸһͼ󣬰ѿڡȫʫ˵Ĳ
׼ȷ¼ʫƳдʫΪţʱ

ʦѡȫʫȫһ飬ҲͿˡ
õʫʲô֪ʫڡѧʦҡ¡
һĵĺã֤ˡһװ˵ġࡱָ˿࣬
ǽ˵޻û˷ƳҲС¡ǲǡ¡ֲ
һ˼һʦڵ˵Ƴá޻£
ľƓ޻˴Ц޹صġ¡ΪԼߣҪ
˱ѧʣȻ죬ȴһ¶Թѧ֪ԽҲ
ԽЦ

2013.5.30

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

ֱ䣺ӽƷҵ

20135303430Ѻſͻˣ

ۣλѴҺãӭѺſͻֱ䡣ݹ۱Ʒ
ҵڹڶʮķչгȡĶǼ򵥵ĴַʽʹһЩ
գΥƷҩƷͷȷʽĲȡ
ҵΪ˹ҩƷܲŵϸִͱ׼ҩƷֱ걨ɱ
ƷȫȨڲˡƷҵӰ쵽Ⱥڵ
ȫ뵽֪Ҳ֪רҷʦʹ
һƷҵ

ӣҺã2000꿪ʼҺͱƷҵʮսܸ˽
лܺʹҽһⷽᡣ

ˮľ껪۵ЩԭزƷڷûи

ӣϳԽԭ׺ͳԱĵһûôҲиá
еĽԭġһǵáҡ¼

÷֦ϣӣгԣϣֲƷ

ӣҲκβƷԲ⡣ԵĻ
Խ׼еĸŮиҶƼԤ̥񾭹ȱݡǼ
֪ȷйЧıƷ

ӣʦƷǲǻƭ˵ģ

ӣƷȫƭ˵ġеıƷӪֵȺб
áеıֵδ֪ڻɫشеޱֵƭ
ˡгࡢУ˵ƷƭˣҲԡ

С54399167⵽ʲô⣿

ӣųƳܹʣٴ֤ﲻЧ
ǱƷ˵ͬʱмҵ˶мЧ˵ⲻƭɵ
ӵмһҪʲôʣȻôš

ٻٵıƷ棬ǷҪΣ

ӣ˴ԼٻɶӰ죬ӦóеΡӦ
صġֻ׬ǮȴóеΣӦĺ¡

Ѻ54398107ýӴ˶ԱƷҵĹעȣһЩΥ
Ϊʾ˵Ʒҵڱħӣô

ӣƷҵһٹ͸֧ŵƭҵ
¶ûԶԶܵҲԶԶħ⡣

Ѻ54398960ӰӦúúôһݽ磬컨׹Ķ


ӣ̨Ľз½øøǵʣͿڷԭһ
øҲᱻֱãοʲôø֪ԿԿ϶ƭ
˵

Ѻ54398460ǲеıƷǺ˵ģ⣬Ƽ
ֺõıƷ

ӣ׼кڸŮӦҶƼĸιӤӦά
DڸŮӦƺάDԸάƬҲԣûʲô
ϾЩˡ

Ѻ54398832Ŀǰ˵ձҲнԭ׷һĲƷۣ
ܶ˴ӹطûⶫһöû𣿻᲻
һЩأ

ӣϿԿ϶ⶫúͳʳﲻ
ݷ治καЧıЧĿǰҲûпɿ
ŵʵܹ֤ʵܳĿҲڻСֻпڷͽ
ԭ׻Ĺؽһ˵ͨҲûٴ
ȷ֤ҽҶҪš

5KE4o1һбҪӦճõ׷ۡƬ
άصȵӪ 2һӼǲĸ쳣

ӣӼαѧƷƭ򱣽ƷõģҪš׷ۡ
Ƭ֮಻˵ȫûӪãֵճʳӦӪ
ɣֵûǮȥЩԡҪάƬĻҲӦôӱƷ
ҩάƬˣҲб֤

ESyx3ʦãгϵ屣ƷǷᱻ嶾ص
Ⱦؼṩ

ӣױжȾҲױؽȾ
ؼǣ岢ıֵıֵǱģʲô

*pIFvʲôӵҶᲹã

ӣֻҪǴҩҶᲹߺҶĸάƼͶá
Ҫ򱣽Ʒ̳ģǲ󣬲Ʒޱ֤

Һܿ116Ѻݰҩҵһϣ͸ԭף

ӣֻҪǽԭײƷûʲôãĸġ

LEoUu밲кõĲƷ𣬻Ƕƭ˵

ӣֺųơֱıƷҪôôҪôһЩôǼǮ
ף˵ƭ˵ġ

idiotluffy50ѺҦԵҲûЧô!

ӣҦֻǸǣֲҽѧרңʹƭˣ
ҲȫΪ֪ȥƭ˵ıƷ

ioxkvʦ ʲôƷ Գ԰

ӣкųߵıƷƭ˵ġĹѾպϣʲ
ôߡûбպϣ֤ӪʵĶԼߣ
ҲʲôƷûκιϵ

BabyBabyOneMoreTimeYeahԶĲݿa

ӣĲݾëëʬϳĢĶ˵һë
ëʬĢܲʲô壿

Ѻ54398961ܶڵıƷҵԡͨFDA֤
ΪͷFDAʲô֤Ȩô

ӣFDAʳƷҩƷֵļƣʳƷҩƷҵһƣ
ͨFDA֤ϵڻùʳϡǣFDAֻ֤ҩƷ֤Ʒ
ǺųѾFDA֤ıƷƭ˵

oAPxsƲƷЧ

ӣûЧκδƱƷҲƭ˵ġЧΪá

VCiZ1嵰׷ӪֵĸƷƵĺһЩ

ӣ嵰׷۵ӪֵҪȴ󶹵׷۵ĸһЩǣһ
һţ̣ӪֵҪڳһӵ׷ۣȥǮ򵰰׷
Ըʲô

Ѻ51032632佺ô

ӣ佺жԳɷ֣ųĳҽơáǾ
˶оĿǰȻûжۡҪԭΪ佺ĳɷָӶ䣬Ҫ
ҲͲ̫ʵ

mHqIqʦ¿ƤƵô¿

ӣҲеñĶƤġʲôƤҪɷֶǽԭףҲ
͸ԽԭױƷһеӪֵûá

EPio˵˵ΪαƷгй½ôţô๫֪
ôԱôשôųĵýôڸʲôӣ֪
ô

ӣҪô򣬳Ϊ漯ŵһ֡Ҫôµˣҿ

NPE73ŵ֭𣿺ù

ӣƷ˵ŵ֭ﺬһɷ֣ǹƭ
ӺġΪֹûκ֤ܹ֧ŵ֭бõ˵
ŵ֭ĳΪαִڹû˹ܡ

CXI#rʦҩһЩƷôƽʱ轾
ˮЩ

ӣ轡ջֲ֮ﻨżȺ޷Ϊӻܲһ
ӪءõҶֵġɷָӵġζصҩƷҪ
ˣǲûãиá

Ѻ54398615ǰֵúȵĽԭ¼ùڽԭ׵
ۻزų洦

ӣᡣزŴͲȥٱƷ⣬ٱ
ƷҲй˷ġ

fBIkvʦд鲹άcܸƼһӵ
𡣣ְȫЧ

ӣҪάCάCḻˮ߲ѡ
άCȱ֢ҪάCƼֻҪҩƼʲô
ĸӶСҪע⣬ûеάCȱ֢άC


VCiZ1ʦơεıƷ

ӣûãĿǰ޿ŵĽҩĺȾưѸκȻĻٺȵ㣬
ҪЩƭ˵ĽơαƷ

4#GioĲûֵ㷭±ݸĿɣСѧûҵͳ
ˣĻ궼

ӣԼûͳˣݸĿжĲݵļأֱ
峯ıݴ²жĲݵļءʹݸĿмΣƭ˵ġ
ŵĶˡݸĿ˵лβ

ӣҼסһ仰ȥõòĶǾͺܿܲ
ģҪл롣ԱƷˡϰΰٲĶǲڵġ
ллҵĽ쵽˽ټ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

΢̸̸Ф

201352911:00~12:00Ѷ΢΢רϷ԰22ڣ

ͯδ : #ʷ˾Ф#Фûκû
ߵĲ

 : ФФϷ仡85%ɹʣԱ˽Ϊ
ʾκγɹߺ־ԸߵĽǳɹΪ0ûһ
˵ͨӴ򣬰ýļɹ
39%Ȳзˡ

 : #ʷ˾Ф#˵Ӧǲҽ
ȥˣΪʲôҪߵһˣȥ
Ӧûܺ°o(_)o 

 : ӡ࿴㡱20Ф
һ߼˵֪Ф׵£ǰһҪԡ
οЩý塢֪ΪФԩ˺ܶˡǲ
ͶҽӦܲųֹߡ

ͯδ : #ʷ˾Ф#һ·(@fangzhouzi) 
ʦʱΪ˵ǳϮԲŶٵ

 : ĳЩýұ2001ФѧܸҳϮ
ģѧٱҵʱ֪ɵġ2005ǽ
¶ʱһʼҲ֪ܸҡеý˵ҺФи˶Թô
أФΪʲôҲҪϮ˵ͨġ

˼ : #ʷ˾Ф#Ф20Ф
Υֹ

 : Υġѷŷ˵Ŀǰ
ٴΪûл׼ίֻǡ顱Ф
ҪͲܡĮӻȨ档

 : #ʷ˾Ф#ûпܾ⼸꣬ȡ
ͻ?

 : ûСǰһҽԺФƭʮ
ٴ飬Ҳɹ

Ʊ : #ʷ˾Ф#٣ί
ȻڱֹġФϷ仡ֻǡ顱
Ҫչðҷɷ֮踣ⷽ棬ѵҲ

 : ФڻûлҽִʱڰҽԺ
ָߵͣФ20ί֮֮
ǵľٱǷиܵأ

BLACKEYES : #ʷ˾Ф# Ф人˾ŵ
ٱܸΪƣ

 : 人Ժר˵״ִ֪ͨ
ФνܵԼƵоФʤߣܰ⳥
ʺŻߣЩ˵人ԺФĹϵܲ򵥡

 : #ʷ˾Ф#ҽƼ˾绰
ǽֹФǻ𣿻ĸŲܹФĲΪ

 : ӦܵġҶԱӳФڷǷ
ФܺҲϷùֻ˵Ҫ顣

xiangjinsong : #ʷ˾Ф#Фȥ
ЩʵڵĻҽˮƽô֪

 : ƭҽ˵Фɹ85%ʵ0Ф
ڸҽԺĳʵֻԼ˽ҽԺ
еҽҲΪ档ҲвҽѧڿýϹ
ҽɷʱ˵Ҷ֪ǾǸЦ

޹²ݻ : #ʷ˾Ф#˵кܶ໼Ϊûб
κö𣿺Ϊʲôûеó˵أ

 : 2009ٶܺҪǷԺԸɲ
ڻûһܹ

_520 : #ʷ˾Ф#ڶžҽҩ
ǷζȱѧԭФɱδ
ļҽҽѧֻҪʽЩΥĵýͻṩ
оýƺԷӡ

 : ҽҩǳҵڵǰй²㲻
ФϴԲڵ̨ϵбΪФϴ
ףмֽýҲΪϴףкͯߣνҪǮҪ
ġ

־ : #ʷ˾Ф#ҹҽϵͳµ
ǷҪ֤ЧʩУ

 : 2009꿪ʼʵʩġҽƼٴӦù취ФϷ仡
ڡȫԡЧ辭淶ٴоһ֤ĵҽ
ƼͨٴФδͨ鱾Ͳο
˷ûȥܡ

 : #ʷ˾Ф#ʷʦй
Фåҽȴ̣ƹ㣬һʲôľʹ
˼ͲȥЩ

 : ܶ˽⵽ôͯرƶͥĶͯФ
󵼣ҵԪȥФɹзϺ󣬶
ߵġҲ˵ѧˣֻҪ֪Ӧƭˡ

ʱǨ : #ʷ˾Ф#˾ϣĽͣģ
㲻֪ΪԹΪ׼ӡΪţֹĳԹʾ£
֪ý屨ðüë

 : ŷŷʽФٴ
𣿺οФû׼Ͳٴ
õصطĽֹ˲ûнͿѵ
˭㷢һͶԲ׼ٴΪûн

--V : #ʷ˾Ф#Ф(@chuanguoxiao) 519
΢ֻФڸ飬Ч˸ˡԼС
ˣˮʧָܻرǡФڻ
ȷЧ

 : һֱϡýϲͣشγɹ
ҪȥʵԱ˽Ϊɾܾĳ߼Ϊ֤
ͬ͸¶߼Ԫж

ӽ : #ʷ˾Ф#ФɱˣΪôʱ
س

 : ԺԺΪǹɱˣΪѰ£
ʹѰ£Ҳ5ֻ꣬赭д¡
УûõӦеĳͷܶʱسҼΪš

˧ʦ : #ʷ˾Ф#λʦǺã
ΪФԷʦԱأ

 : ֿʼǴڵģܲ

˧ʦ : #ʷ˾Ф#ûϿɺͱϵ
һֶĲФȻЧ붾к

 : ȶӡٻҴĺôФǴ
γɹЧƭߣһý塢֪Ϊط
Ժط֧֡Ƿӳй¸ĸ͵İ
֮һ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

             Ӫרҡĵ֪

                    ӡ

뱻ý崵ΪӪרҡĿѧ΢
Ϸһۣ漰ԭס˶Ͱ󶹵׵⡣Щ۱
¶ѧĶҽѧ֪İĳЩӦдɲ
£ҡŪڡƼҲд΢һ
ҽ׫֤ڽԭ׵ϵƭӰ
ġ

һڽԭ

˳˰ԭʵ@ 
http://t.cn/hGYQYQʵĵƪԭ׵Ļʵ
˵ϳƤĽԭףҪҪǸʰᡢ
ᡣǰǿԴתģֻʳлȡ
ʵϽԭף1ͣ18ְᣬ7ֱʳлȡẬ
лǰǸʰᡢͱᡣڽԭе
ܵͣÿ1000лвź20ȥǿǺϳɽԭ
ҪҪᣬֻʳлȡɶ˼
ᱣƷİУ

ĸлĶߡָµĴɶʱġĶߡ
ˣһûҲͿƪҪġ
ߡлĶߡָΪƱ˵
⣬ʰᡢ᲻Сԭ׵ĺϳ
ʹRNAΪģϸкϳɣȱеĸᶼУôҺ˵
⡱ԭ׽ṹmotif˼ԭ׵İ
һĹԣʰ--X͸ʰ-X-ǻ
֣ΪmotifеXʾmotifǸλõİб仯
ڵȻʲôͱְᣬĸ
ᶼԡⷬƱ籩¶ȱﻯѧ֪ʶѹֻȥƷƭӰ
С

˵иְɴȷġǷͻ䣬
ÿ˵Ľԭ׵ĸְУȷģǡȷ
ġ˵⡱˼λõİûضҪ
ְﶼӰγɽԭסְ᲻滻
Եġԭ̸Ǻϳɽԭʱ԰󣬲Żȥʲôǰ
ǿԴתģֻʳлȡ˼
İпޡֽƱ˵ָǵʽṹҲǺ˵ԭ
motifеXָֻǸλõİб仯ְ
ﶼӰγɽԭסеλõİҪˣһŴ
Ehlers-Danlos syndromeǽԭIalpha Iľ134װȡ
µġĻȴӷѧﻯѧ101ѧ𣬰ѧĻ
Ūˣװá

˵иְɴȷ¡
˵ġԭ׵ĺϳʹRNAΪģϸкϳɡȻָ
һضĵףұ¶ѧĿ˵ԭ
ǡһ֡ףǡһࡱף˵С¡ͬɡ
ҳɲĽԭϿԴ˵ʵͬĽԭ
֮䣬¡Ĳ𻹲СԴȥ
ڵĴˣ޻кķڡܿ۵Ĺ̺ͽ㡱Ȼʲ
ôУȴ¶䲻ѧ

ųҪۡѧ⡱Ҫȷشĵֱܷӽ
ѪҺܣôǷܲҩã20109
ͻشˣʲܿڷֱշһԭԭȻ
⣬ȶĵܱգΪ²أ
prionҩáǱʵ֤ģ
ǷҪʵ֤⡣Щ˵컨׹ĵĵʻ߶
ĲƷӦֱ˵ԡֵʿڷ֮û񶨣
ǾһЩܱյ⣬һȦ
д˵Ҫʵ֤ʵϾǱΪٱƷ绤
漰ʵ⣬ûȷ֤ʱӦòȡʲô⡣ڼ
ĳֱֵܱաȷ֤֮ǰӦԡһ㲻ֱܱ
ա֮ġ⣬ٵƪģʵƪ
ʳӰ쵽Ѫаᡢĺȵطڣʲôû
ϵԼ򿴲Ļˣαѧõġ

еλǲǴҵгģԼˡ
25ڣΪʲôת򡷣еĵʱ˳֮
϶ᱻֽɵİᣬԲͬʵİ˵
һġֻһСûзֽȫĵƬΣģڳ
Ĺ߷ӦӶ¹http://t.itc.cn/fMn53 

ĽƱ˵ΪʲôתһжԵǶΣ
ڵ۹ȷʵҵࡣǸʱҶԵֻн̿ˮ
ƽҲֻдںļУӴ˸µоڵ
յ˽Ÿ롣˽ĴоҵʶҲ
չơΪʲôת򡷷20103£һ9£
Ѿڴ̸ʱƷܹ巢òѵҵĹ۵ʱˣ
˼£ĺü꣬Ǹķ̥ǣ
ҵרҵֵǣļȻ20109ѶԵˡר
ҵʶ2011桶Ե2ʱȴȻѡҵġΪʲô
ת򡷲ĶսȥΪ˷޳ԭܼ򵥣
ҽѧרҵʿⲻѧ⣬֪Լ˵ʲô

2010дġΪʲôתһԡеĵʱ
˳֮϶ᱻֽɵİᣬԲͬʵİ
˵һġΪ˵ԼתģʵҲǵʿѧȨ
תʳƷĹ۵㡣˵ʱԵĿܡҵ
ࡱǾ˵ڡרҵĿҪתˣǼФ
ֿ֮ȥ֮籧ţϲᣬԽԽˡ

˶Ͱ

ڡûкϷȫġ⾫һ˵һ10΢
޾˱ֳ֢״١˶Ͱ˵һ
20000΢ϲпֳܱ֢״ڱȽҩĶԴС
ȴɾǰ޲ֻ֣ó沿֣ѵ˵
ʳƷȫ׼ʱ򣬶⾫ʲǲ÷˵ġ֢״
Сǲ֢״ļNOELԴ˵Ұ20˵
NOELȻƪʹӵ⾫Ūڵ 
һʱƼֻڱȽҩĶԣʲôʱ˵
ƶʳƷȫ׼ˣʲôʱᵽNOELˣֶȡ壬Ƿǳ
ķ̰ΪҲӵǷŷ档˵15ˡֻ
ǳӵСʵ˵15֮ųֲ
ӦNo adverse events occurred after the 0 mg, 5 mg and 10 mg dose. 
After application of 15 mg, 25 mg and 40 mg, there were nine reports 
of sensation of increase in heart rate and five reports of sensation 
of heart pounding.

һ˵ĳӼںʹʱܰȫ˽Ҫ
ǰô˵ô˵һλרҵʿģ
ӻΪӿյ⾫ȫ׼ûˣڳ15
ôܻϿɵ˶Ͱȫ60΢/죬ϣ
ÿڷ60΢˶Ͱ

ڴ󶹵

Ϊ׷۱Ʒе˵˵󶹵ȱ谱
ϹұȥʳƷרҵʿϿΣǸ
ΪĳƷƵ׷Ӫʦһ֧˵Ҿ˳һ
ʰˡũҵоԱдsoy protein is not an ideal 
protein because it is deficient in the essential amino acid methionine. 
 󶹵ײһĵʣΪȱ谱ᡣ
http://t.itc.cn/fyFwh ƪһģThe biological value of 
soy protein must be considered inferior to that of casein protein in 
humans. 󶹵׵۱뱻Ϊţҵס
Ӫֵһָ꣩http://t.itc.cn/fDgmm ˮҲ
Щġ

İѡ󶹵ȱᡱɡ󶹵ײᡱ
СѧĲ񣬶Ҹ˹ȻҽѧĴС
˵ˡάCȱ֢϶ΪǸһάCûˡ
Ȼⲻαѧ˱ŸߺǶԵġ

һ˵Ĳġȱһʣôũҵ
ԱõӢdeficientһûκģȴ
ũҵоԱĲΪƾҪũҵĴ󶹵ݣ
ᡣ˵˵ģĶӢҽѧרҵף֪
һ㶼ìܣмᣬȻdeficientһҽ
ѧרҵҽѧרҵ׵ˣͨԼļգ
αѧΪϴ󣬱ýΪʳӪȨʿ

ҥ˵˵󶹵ʵס֤󶹵
ʵסʲôʱ˵󶹵ʵף˵ǡ󶹵ײƷ
õĵʡ뼦סţ̵ױȽ϶ԵġΪʵ
ͲٷֳûˣPDCAASӽﵽ1ĵףȻñָ
ֳûۣⷽоеǣϼסţ̵ױȴ
׵ƷʺáӪרҡԴãȻ֪

ЦǣĲ֪󶹵ȱӪѧʶ֪
гǿĴʳƷ֪ϱӼᣨÿ
Ϊ˻1Ԫ֪оӼẬת󶹵
תһ׵׻򣩣PDCAAS
󶹵ײȱᡱαѧ˸һߺǶԵġ
ÿѧ˷ӡڱαѧ

ġĵרҵ

ҺΪζѧ֪ҽѧģƺ
˷顣ԭҲ˵ȱϵͳĻ
죺ơ˶ʿʿרҵͬģ󣩵ļУ
䱾ѧҪĽ֮һΪѧ廪ϵ93
ѹֲѧŴѧﻯѧЩûϵͳѧѧ
ǺѿԺĲϰѧĻġ1998ҵתϵ
3˶ʿæſпG2001תеնȴѧ3ũҵ
Ĳʿ䲩ʿоǰѵʷнĭĭ
ȶԡ黯оýʳƷӪʳƷȫ
רҵʿʵʳƷݵרҵʿѡݡȥˣֻʣʳƷ
֣ܻ˵ġ

ũҲѧҽ˶ʿѧɣʿѧֲѧ
Ȼȥũо΢ԴãҲýΪʳƷȫרҡʵ
ʳƷӪʳƷȫУһǿ٣ʱţ
գҷҵ΢ݱõϽΪ
ǶϣԸԻˣһ̱ӣȫ¶ڡҸЩ
ýϷˮҽѧ⣬ʤ֮䰡Ҹ㲻׵ǣЩˮΪ
ʲôû֪֮սңɼý϶ˣͣԼ
ȨˡҲְֻܹۣҵǱһش
ˡ

2013.5.27

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

ѡһһӡˢ

鹲50ֲ֣֪ʽӽ֮һһŴ0.1
ӦͣУڸӡˢٷСִＯĺ
벿90дʷƷʱûд뷨ֻһһ
ãټĻֱʲߣеǳʱνҲжദ
ǱУȷĸĴˡ⻹бУøľıԭ㣣ҽ
Ҫڵڶӡˢʱָ磺

p.3ֲƽҿΥ˿ѧʱ򡣡ԭΪ
ֲƽҿΥ˿ѧ塣
p.3ҪʱԭģڱҪʱ򡱡
p.9ȶԣѧǷĸı䣻ġڽֻɵݱ䡣
ԭģѧǷĸı䡣ġڽֻ̲
ɵݱ䡣
p.9ԭлϵĽԭΪԭлϵݻ
p.9, ΪִѧҲˡԭΪΪִѧ
Ҳˡ
p.428䲻븯ܡթšҡԭΪ
䲻εĸܣ˾ĺڰõթŵ٣Ļҡ
p.439ĹľδĳΪ֮
͵Ҳһ˾ĪΪԭǣ
͵Ҳɴ¹һĳôĸʲôѵ
¹
p.468ؼκʹọ̈˰˵ǮԭΪؼ
κʹö񱱴廪̣˰˵Ǯ

еľӱУɾˣp.471һ䣺ǲ
ʲôϷʹƲ桱ˣͷҲǼ
ƨɣ

p.380ϺϷʮУĵʫ˴һҺΪֹٲƽ
ֻýɢһ󵱾ֿʼٽ֯¿ͷĿԼ
Ӳ˵ġһ䱻ɾУ⡣ǰǸҺá
ûˡ 

p.417 ĳ˻¼жԵ˴Ϊػ֦һ´飬
м㣬֦ȻǹĲиˡ֦֮
ۣȴ쵼ʹͣǽ¡ֱɾҲ⣬
Ǿ䡰쵼ʹ͡û䡣

л˶ǡϸޡ߽010еĴ5zongհס
shishanyylbmsshsyƵҡҶϡССܡǹիȻ
2013 УѷֵĴ£

p.13˼Ȼ壻˼лԭ壻ķֺŶӦ
Ϊšԭ󣬴ΪУ
p.20ͼƬڡӦΪͼƬڡԭ󣬴ΪУ
p.21ͼһɫ汸һɾˡԭ
󣬴ΪУ
p.35ǿѧôô˵˲ࡱɾһô
p.39Ȼǵ¹ʤԡӦǡӡ
p.45ִﲻɼƴġӦΪִﲻ
ƴġԭ󣬴ΪУ
p.75ûһABOѪͻĳеġӦжšԭ
󣬴ΪУ
p.82ͨһ̡̥ѡӦΪϡ
p.1440.6180339887...ӦΪ- 0.6180339887...ԭ󣬴
ΪУ
p.145ķ̣^2 - - =0Ӧǣ^2 - -1 =0
ԭ󣬴ΪУ
p.157ȻģĿСɾһġ
p.169ÿϳԵġӦΪ
p.176ÿطֹϸҲȾЧġɾҲԭ󣬴Ϊ
У
p.202ҵթӦΪҵթۡ
p.282ȫж20ˡ20֮ȱ֡ԭ󣬴ΪУ

P.287ϲӦΪ˺ϲԭ󣬴ΪУ
p.309ǰʢʱе˾ǰ֮ʱСӦΪ
ʱ
p.310گٽެӦΪ
ġ
p.311ѿʵӦΪ
p.311Ȼ̡ӦΪ㵡
p.312ʹ֪Ҳ֪Ϊաڶ֪Ӧǡ硱
p.313˽ѧѧӦǡ˽ѧְ
p.318ʮ꣨1383꣩1383Ӧ1391
p.324ʴ˵ɾڶ
p.353οӦΪο塱
p.355οӦΪο塱
p.360ʴӦΪʴ˴Ҳɣ
p.360ӦΪ
p.375Ҳ֪δܳٵԭ֭ԭζӦΪ
p.383ȥ𡱡ǡ̸ǡֺӦΪ˫šԭ
󣬴ΪУ
p.385漣ĵĵжһġ֡
p.402ҡӦΪҡ
p.403ӦΪѡ
p.408, ¹ǧױסһֻСǧסӦΪԭ
ΪУ
p.416ƷӦΪƷ
p.417ڻʵ۾ʹӴ˲볥֦ӦΪ
p.417ΪѮҾǰ˼ҡΪӦΪġԭ
󣬴ΪУ
p.417֮ӦΪЮ
p.418ŵġӦΪټġ
p.419ɭɭӦΪ١
p.424̨ˡ顱ӦΪ顱
p.435ʷɷȿܽҳܽڡӦΪؽڡ
p.436漴ӦΪۡ
p.438רҡҡӦΪʡ
p.451ҲܡӦΪҲ޿ܡ
p.455ͷӦΪ
p.463ǲҪٳСɾǡ
p.463֪֮ټϵҺǿӦΪ顱
p.475ɧŪˡӦΪɦŪˡ
p.478ʵλԱԼǺܲģӦΪšԭ
ΪУ
p.481еӦΡӦΪ
p.482ңڡӦΪңڡ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

GSKзܲòؾNature Medicineٶ·ְ

ߣformergskemployees

Ϥ ʷйзģGlaxoSmithKline R&D China)˲
2010귢ڹʶ־Nature Medicineϵ٣뿪
˾ڽܵ顣ģNature Medicine 2010,16:191-197)ĵһ
ѧXuebin Liu)ڣStewart Leung)ͨѸǲؾ塣
ıϸ7IL7Զ෢Ӳ֢ģͺͻѪҺTH17ϸ
ؼãIL7ܼʵԶ෢Ӳ֢ģ
Ĳ仯ٴˣIL7忹强ΪGSKƶ෢Ӳ֢ĺѡ
ҩﲢٴ飬ؾΪGSKйзĵıˡ

ӵٱNature Medicine ͸ʷܲص飬ڷ
ʵٱһµɳ2013523Ϻʷ
зĶԸҪ߲ؾ塢ѧڵ˽˵ѯʡ˲顣
ؾαʵʵ𽥸ˮ档

1. ͼ6Figure 6)йصIL7 IL7׿Զ෢Ӳ֢Ѫ
ҺTH17ϸʵα죡ͼнڽ
˶Ƕ෢Ӳ֢Ѫҳͼ6ԭʼʵ¼ȷд
ʵڽѪҺƷʵǰѧڡؾ޷
, ֻгͼ6еʵԽˣжദժҪʵ鷽
۲֣νڶ෢Ӳ֢ߵѪΪʲôҪôӽ
Ѫлõʵðڶ෢Ӳ֢Ѫأѵ
Ǵʵԭй޷ռ෢Ӳ֢
ѪйǸòͷؾҽѧԺǩһݺЭ
飬ʱαҽѧԺڵĺ齨ռ෢Ӳ֢Ѫʵ
顣 齨ռļѪʵ飬IL7׿Ч
TH17ϸѧڡؾյһǳʧ
ѪϼʵõνIL7׿TH17ĽȻ͵
ѳǴӶ෢Ӳ֢Ѫлõݡⲻ֪GSKʵ¼
ϸĹʩԭʼʵ鶼¼ڵӼ¼electronic lab 
notebook, eLNB) 60꣬κθĶ¼˵鲢δ
Ѷٹȷٵʵ黹֣ͶʱȻںЭ
ǩʱ䣡ɼоδʽʵˣѾͶ
ˣGSKĹ涨ûЧЭⵥλʴҲ
GSK Compliance Ĺ涨

2. ڸĸͼ7supplementary 7) УIL7ٽMSѪҺ
зֻTH17ϸIL17ı?n?=?20?ͼ2020Ѫ
Ǵ20Ѫлõ𣿻شǷ񶨵ġϤǽ
Ȼˮѳƽ20Ѫɼͼ7еʵ
α죡ȤǸͼ7ʾͳѧp<0.001, ڵ196ҳ
֣Ϊ "Furthermore, in vitro exposure of 
differentiated TH17 cells to IL-7 led to significantly increased 
production of IL-17 (n=20, P<0.01)"ͬһһp0.001, һ
p<0.01ɼαʱôСģ

3. ֵʵǴӶ෢Ӳ֢СģлõġȻ
޷˾ظҵڹܡǲҪ
ʵҪִͬ־̤ʵ

4.2010귢ģ2013걻飬ؾٵ
ʵǷ֪飿ӵ֪֮Ϊɼһߡؾ522ս
ϼ֪ͨ˺͸ĵҪѧԼҪѪƷʵ
ִߺ齡ϼȫܵѶؾȥ
ݳԲߡָʹͳһھڸʵ࣬ؾ
мѧڵɼؾ岻ȫ֪
Ҳı

ҲҪʲܣ1ೡϣͨǾƺᵽƪ֮ʱ
Ժ˵ɸĵʵ1000ԪҡڿڹؼǮ
ʵԱģ1000Ԫ˺δ2ȫƶ£ɿ
ϣIL7忹ΪѡҩƵٴ׶Ρû
αʵݵٴGSKɶľʧԻߵȫ
ɶǱвGSK͹ƱӰЩʱ
Щʲôأ3 ںܶೡϵݽʱǿѧоҩGSK
йзĵɫʱûð4
ԼװɿѧʦԳѧ֮һȴһ
١ˮ伫ʱʲôǿѧ¡Ϊʦʦ
5ȥ20133·Nature Medicine Ļ2011귢
ImmunityϵĻո޻صNature ImmunologyйSirt1RORgt
Ĺ£˷ʱˣмɻ֪֪
Щ¥ڴɢȥ̫֮ʱʧ

ܣܶ˶Ϊ󵨡Ҹɣ²߼
ˣ̫ͱ޴ΪҲ߯һ㣬ǰð
ѧ֮һ˵Цϣǰӷٴ
鱻FDA棻ǰNOGOĿزݡ̫ƽ£
GSK沢??????????  ү˶Ļʹǰǣ
ˣΪʲôҪأΨһĽǻ裡ΪȨ
ΰ֪־ʿвľѣΪʵйΣԶͶ
£˱Ĵɢ

õĻβɣwhat does not kill you makes you stronger. 
عĳŻʱƶ𽥵ǵļ䣬Ը˶̷˼
߰ͷΪǿˣ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

䷢µһЩ
                    
ߣ鰮
 
ǰʱݿѯһЩҰУҪOryza rufipogon  Oryza 
nivaraҰĻУȲ鵽һƪResequencing 50 
accessions of cultivated and wild rice yields markers for identifying 
agronomically important genesNat Biotechnol. 2011 Dec 
11;30(1):105-11ƪµͨѶйѧԺоĺ
˲NCBIݿ鲻ύ
ιҰĻ͵С

ҵȤַĺΪͬͨѶߵһƪ
£ҲǹڻģSequencing and automated whole-genome optical 
mapping of the genome of a domestic goat (Capra hircus)Nat Biotechnol. 
2013 Feb;31(2):135-41ͬҲûύκCapra hircus
еNCBI

һ˵ǵύеNCBIصݿ⣬Ȼ󷢱
£ҲеĻύϢǶѾ201112·ݺ20132·
Ѿʽ˵ڶûκλϢύȷʵ
⡣οƪ¶ȫе£˴Ŀоѣ
ٵüɣѵôǮͷ2ƪ£κ
ݣҲʵڶԲôоѰɣ

ôʲôԭأ˲²⣬ǲݱʲô
أʵǰ˵ĻݵҹάһԵ
ȥ˻ͷŵһTupaia chinensisȫ
ݣǲ鲻֪һһȫݴٳڻ
̫󣬲ܽȫֻ֤飬35Уʾ
25%ҵжлٵĴ󣨲ֳSequence ID: 
ELV14235.1 ELW68196.1, ELW63486.1, ELW54969.1, ELW49150.1, ELV09248.1, 
ELW67516.1, ELW48852.1, ELW47487.1Ҫ£

(1)AǰкBǰлƴһ

(2)еκβλܳһЩĪĴƬУ50
ᣩЩҲκУעڻп֣ܳ
Ƕ鳤Ŀܽӽ˵ںܶ൰ǰгҲ
κƶȵĴƬк⣩

(3)ԵвⶨڱصźǰߺһЩĪ
ĴƬУ50ᣩЩҲκС

(4)ͬʱвⶨкƴӣƴ

ɵǣƪµͨѶͬйѧԺоҦ
Nat Commun. 2013;4:1426. Genome of the Chinese tree shrew
ͬʱҲţôôƪеóTupaia 
chinensis鳤දܽӽһ̫ۡ࣬ȷʵ֤ʵ
֤αҲǺܶΪ˷¶лԭ֮һɡ

: еĲֳ35У9
ش

ǴNCBI鷢ֵһЩдУСĶģ
øҪ£
(1)AǰкBǰлƴһ
(2)еκβλܳһЩĪĴƬУ50
ᣩЩҲκУעڻп֣ܳ
Ƕ鳤Ŀܽӽ˵ںܶ൰ǰгҲ
κƶȵĴƬк⣩
(3)Եвⶨ,ڱصźǰߺһЩĪ
ĴƬУ50ᣩЩҲκС
(4)ͬʱвⶨкƴӣƴ
 
1Yorkie like protein [Tupaia chinensis] Sequence ID: gb|ELV14235.1| 
MKVLVLLAAIFLVAIQAQADPLPARTEEALDQEQFGAEDQDVPVDFAGEESSALRAAGESMYSGLSMSSCSVPQTPDVFLSSIGEMDMGDTVNQSTLPSQQNHFLDSLDPFLE
ǰ50defensinǰУYorkieУƴӴ
 
2Anaphase-promoting complex subunit 11 [Tupaia chinensis] Sequence ID: gb|ELW68196.1| 
[1  mkvkikcwng vatwlwvand encgicrmaf ngccpdckvp gddcplvwgq cshcfhmhci
61  lkwlnaqqva aalalc]lllv ppssa_wykpa agpsyysvgr aagllsgfrr saya_rrpelp
121 igagprdpeg afpelrslal cvkevtpnlq scerlpdgrg tlqckadvfl slraadcsst
 
򲿷ΪAnaphase-promoting complex subunit 11
»߲Ϊneuropeptide B
ƴӴ󣬽Anaphase-promoting complex subunit 11neuropeptide Bƴһ
 
3Orexin [Tupaia chinensis] Sequence ID: gb|ELW54969.1|
1   mslfpttseh ykpqvpgsrs qwtaarfqat rttadifpgc ptlssrhnep slhkgllpll
61  llllllppal lspgaaaqpl pdccrqktcs crlyellhga gnhaagiltl gkrrpgppgl
121 qgrlqrllqa sgnhaagilt mgrragaesa prpcagrrcp vvaatsiapg grsgv
 
Orexin
1   mnpsstkvsw atvtllllll llppallspg aaaqplpdcc rqktcscrly ellhgagnha
61  agiltlgkrr pgppglqgrl qrllqasgnh aagiltmgrr agaepalrpc sgrrcpseaa
121 ssvapggrsg v
 
ֵOrexinǰ嶼130ңбȶԿԷ
Tupaia chinensisǰźǰĪ50У
򲿷֣50Ҳκԣܿдֶ
󣬶ƴӴΪTupaia chinensisǰǶֻ˲ź
У壩
 
4Appetite-regulating hormone [Tupaia chinensis]  Sequence ID: gb|ELW63486.1|
1   mlsprtical lllsmlwvds aaagssflsp ehqkaqqkke skkppaklqp raaegslppe
61  dgsqaegaee eleiqfntpf dvgiklsgaq fqqhgqalgk flqdilweea egksppgsgs
121 rgfhqvpegd phvgntkppp qhltlsfkff aighvclpet erqresekss pgwgrprcnl
181 fsilpeilgm hkyrv
human
1   mpspgtvcsl lllgmlwldl amagssflsp ehqrvqqrke skkppaklqp ralagwlrpe
61  dggqaegaed elevrfnapf dvgiklsgvq yqqhsqalgk flqdilweea keapadk
ֵAppetite-regulating hormoneǰ嶼ֻ110ҵ
ȣTupaia chinensisAppetite-regulating hormoneǰȴн200
ᣬԣTupaia chinensisAppetite-regulating hormoneC-ĩ
Ľ90ᣨ岿֣вⶨƴӴ󡣶
90ûκУúͻȻ
 
5Protachykinin-1 [Tupaia chinensis] Sequence ID: gb|ELW49150.1
1   menaqglrsn vrskhpalqg fgfvtcapve mvhavmnarp qgksspnkrw lvlspaqeve
61  vvletsvvie kvvlvvmttl vmeetsvvvv almaaivvvd taevgiaimd lgfprhssvg
121 gdsaegaaae rgpgerfpha naplclppag pgglkksdmk ilvalavffl vssqlfaeei
181 ganddlnyws dwsdsdqike elpepfehll qriarrpkpq qffglmgkrd adssiekqva
241 llkalyvgye rsamqnyerr rk
 
preprotachykinin I [Tupaia belangeri].   
1  mkilvalavf flvssqlfae eiganddlny wsdwsdsdqi keelpepfeh llqriarrpk
61 pqqffglmgk rdaghgqish krhktdsfvg lmgkralnsv ayernamqdy errr
 
бȽϿ֪Tupaia chinensisProtachykinin-1 N-ĩ
˽160ᣬΰҲκУٴ˵
ͺƴӡ»ֲ߲Protachykinin-1
 
 
6Neurokinin-B [Tupaia chinensis] Sequence ID: gb|ELV09248.1| 
MRSTLLFAAVLALSLTQSFGAVCEESEEQVVPSGGHSKKDRDLYQLPPSLLRRLHDSRSVSLEGLLKALSKASIGDMHDFFVGLMGKRNIQTGTEGNQENAPRFGTLKFPPSAE
 
neurokinin-B precursor [Sus scrofa].
1   mrstllfvai lalslawslg aaceesqeql mpggghskkd snlyqlpssl lrrlcdsrsi
61  sldgllkmls kasvgakess lpqkrdmhdf fvglmgkrni qpgtpvdgnq enapslgtfk
121 yppsve 
򲿷ֶУûУܿܲ©ƴӴ
 
7Angiotensin-converting enzyme [Tupaia chinensis] Sequence ID: gb|ELW67516.1|
ʵϣеø϶1300ᣬ2160
1 mvacpmwpgl rcvpppfppf wcpqeeaall hqefaeawgq kakelfdpiw qnftdptlrr
       61 vidavrtlgp anlplakrqq ynsllntmsk iysttkvcfp nktatcwsld pdltnilass
      121 rnyamllfaw egwhnavgip lkplyenfta lsneaykqdg fsdtgaywrs wydsptfeed
      181 leniyrqlep lylnlhayvr rtlhrqygdr yinlrgpipa hllgnmwaqg wdniydmvvp
      241 fpdkpnldvt simvqkvgar wddgreglrg gvrveaapvq ssslehhkvc prqgrqllap
      301 dlspcsqhqg wnathmfrva eefftslgls pmppefwaes mlekptdgre vvchasawdf
      361 ynrkdfrikq ctqvtmdqls tvhhemghvq yylqykdqpv slrgganpgf heaigdvlal
      421 svstpahlhk igllenvttd rendinyllk malekiaflp fgylvdqwrw gafsgrtpps
      481 rynfdwwylr tkyqglcppv vrnethfdag akfhvpnvtp yiryfvsfvl qfqfhqalck
      541 eaghqgplhh cdiykstqag dklravlqag ssrpwqevlk dmvgsdtlda rplleyfqpn
      601 rrngevlgwp eyqwrpplpn nypegiglcs paamgqggaa pglpslflll lccghlplvp
      661 sqtaphqvtv nqgttsqatt ssqttarqaa ssqiattkrp nlvtneaear kfveeydqvs
      721 qvvwneftea nwnyntnitt enskilnrly lsearaglrg lrapvglrse gctsaaplqp
      781 valsgqycsn hreptflkgl pcagcgssal fvcaastpqa qrgqgayakl ppptgplrhv
      841 lqknmkinnh tlvfgtrarq fdvsnfqnat tqriikklqd leraalpfqe leeynkilmd
      901 mettysvatv chtngtclhl dpdlthlmat srkyedllwv wkswrdkvgr eilpffpkyv
      961 tlankaaqln gytdagdswr avyetpsleq dleqlfqelq plylnlhayv rralhrhygp
     1021 ehinlrgpip ahllgnmwgq twsniydlvv pfpsapslda teamikqgwt prrmfkeadn
     1081 fftslgllpv ppefwnksml ekptdgrevv chasawdfyn gkdfrikqct tvnmedlvva
     1141 hhemghiqyf mqykdlpvil reganpgfhe aigdvlalsv stpkhlhsin llasdgggye
     1201 hdinflmkma ldkiafipfs ylidqwrwrv fdgsitkeny nqewwslrlk yqglcppvpr
     1261 sqgdfdpgak fhipssvpyi ryfvgfitqf qfhealcqaa ghkgplhkcd iyqskeagrl
     1321 ladtlklgss krwpeammlm tgqpnmsasa imnyfkplld wlltgrhgeq lgwpeynwtp
     1381 nsarsessss dggrvnflgm nleaqqarvg qwvllflgva llvltsadsl pscshewpan
     1441 fynesearkf lafyeqtaql vlnqfveatw nyvtnitrtn qenmlhkeve ksqfmmyfgs
     1501 rarlfktaql qdldvkrals klqdidkaal pkdelweynk lladmettys maqvclnegp
     1561 cmslepeled imansrdqke llwawqgwrd avgrlirtsf eryvqlsnkv aqlngyndmg
     1621 alwraryewd tleqdleqlf qelqplylnl hasdleqlfq elqplylnlh ayvrralhrh
     1681 ygpehinlrg pipahllgnm waqswinild lalpfpekpp editkimkaq hwnaekmfee
     1741 aekfftslgl lpvppnfwek smferptdgr evechasawd fyngkdfrik kctevtiedl
     1801 lsifhqmghi qyflqyknls vtfrtganpa feeavgsvit lsasshkhlv frgllshqhq
     1861 dseeevnflm gialdkivfi pfgylmdlfr wkvfdgtihk diynqewwnl klkyqglcpp
     1921 vprseedfdp aakfhisase pymryflslv lqfqihealc tasghvgplh rcdiynskaa
     1981 gelladalkl gsskpwpevl ekltgqsevs tkalmtyfkp llnwlvaenv rqgdilgwpd
     2041 fscsfeeket dkmrflglel epdqassgqw vllvlnlfll lvtlglgfrl yflekqslae
     2101 dsdasitmpk ayflglrmep hlvarrqwmm lglsfilmlc siglairvft qhngkppwmk
     2161 tewwssd
 
angiotensin-converting enzyme [Ovis aries].
1 mseprgkqrg etqlipkeqk egadrlgiip dertkaggss mvrrahmsse pqaaeqeeaa
       61 llsqefseaw gqkakglfdp vwqnftdptl lriigavrtl gpanldlekr qkynsllsnm
      121 sriystakvc fpnktapcws ldpeltnvla ssrsyallly awegwhnaag iplkplyqdf
      181 talsneaykq dgfsdtgayw rswydsptft edlerlyqql eplylnlhay vrralhrryg
      241 dryinlrgpi pahllgnmwa qswenvydmv vpfpdkpnld vtsamvqkgw nathmfrvae
      301 efftslgllp mppefwaesm lekpsdgrev vchasawdfy nrkdfrikqc trvtmdqlst
      361 vhhemghvqy ylqykdqhvs lrrganpgfh eaigdvlals vstpahlhki glldqvtndt
      421 esdinyllkm alekiaflpf gylvdqwrwg vfsgrtppsr ynydwwylrt kyqgicppvv
      481 rnethfdaga kfhvpnvtpy iryfvsfvlq fqfhealcke aghqgplhqc diyqstqaga
      541 klrallqags srpwqevlkd mvgsdnldar pllsyfqpvt qwleeqnqqn gevlgwpeyq
      601 wrpptpdnyp egidlvsdea earkfveeyd rrsqvvwney aeanwnyntn istdnskllm
      661 qknlqmanht vkygtwarrf dvtnfqnatm krmikkiqdl eraalpvkel eeynqilvdm
      721 etvysvasvc hkngtclrle pdltrlmats rnyqdlawaw kswrdkvgrs ilpyfpkyve
      781 ltnkaarlng yqdggdswrs myempfleee leqlfqelqp lylnlhayvr ralhhhygpd
      841 vinlegpipa hllgnmwaqs wsniydlvap fpsapkmdat eamikqgwtp lrmfkeadnf
      901 ftslgllpmp pefwnksmle kptdgrevvc hasawdffng kdfrikqcts vnmedlvvah
      961 hemghiqyfm qykdlpvtfr eganpgfhea igdvlalsvs tpthlhkigl lssgdgsyee
     1021 dinflmkmal dkiafipfsf lvdqwrwrvf dgsvtrenyn qewwslrlky qgvcpplars
     1081 qddfdpgakf hipasvpyvr yfvsfviqfq fhqalcqaag hqgplhkcdi yqskeagkll
     1141 adamklgfsq pwpeamrlmt getkvstkal mtyfkpllnw lvtenvrqge ilgwpdfscs
     1201 feeressraa flgmelntdl viswqwtlla lsfvmllavl llgrrlytle kssltqdtst
     1261 qdtrsqgtqs qsprsqdssa ikpasktyfl giamephqvv krqwmllglc llltlgsigl
     1321 iiriftqhnr kppwmrdewg swd
 
8Prothrombin [Tupaia chinensis]. Sequence ID: gb|ELW48852.1|
еֵProthrombin620-630ᣬTupaia chinensisĺ
710ᣬֵûɣܿܲ󣬻ƴӴ緽򲿷50
ҲκС
        1 maqvgglglp gclvlaalcg llhsqhgtep gaggswedcc apppiwgggg ghfgrgdgga
       61 afssfrdfrs prhsrarqaa waransgfle evregnlere cveelcsyee afealespsa
      121 tvsgncaegl gmnyrgtvnv trsgiecqlw ksryphkpei nstthpgadl qenfcrnpds
      181 sttgpwnptv rreecnvpvc ergglhvilp llfpavrlat atrrcevhnc aipghlgarl
      241 wgpvmlvvtl sqsegpaepg swlrpgpgqe hvtvemtprs ggsrvnlpps sepcvpdrgr
      301 qyqgrlavtt qgspclawas veakalskdq dfnpavplve nfcrnpdgde egawcyvaga
      361 pgdfeycdlk yceealeeee eagdgleedp dqaiegrtst qefqpffnek tfgageadcg
      421 lrplfekksl edstekelld syiagrivkg reaevgsapw qvmlfrkhpq ellcgaslls
      481 drwiltaahc llyppwdknf tenellvrig khsrnryern iekiamleki yihprynwre
      541 nldrdiallk lknpitfsdr ihpvclpdke tavrllvsgy kgrvtgwgnl ketwiasvde
      601 vqpnalqvvn lpiverpvck astriritdn mfcagkgykp eeqkrgdace gdsggpfvmk
      661 spfnkrwyqm givswgegcd rdgkygfyth vlrlkkwiqk vieraga
       
9Coagulation factor VII [Tupaia chinensis]. Sequence ID: 
gb|ELW47487.1 еֵCoagulation factor VII440
ϣTupaia chinensisֻв360ᡣҪǰTupaia 
chinensis Coagulation factor VIIǰN-ĩ˽60ᣨ»߲
УҲκԣܿܲ
 
1 mgarllsllg vllwlqgslt agrgqsqpcp eesvggqall lvllvghipe cvlriqamqn
       61 gdqcssnpcq nggscqdqlq syicfcragf egrncetnks qqlmcvndng gcqqychdrg
      121 dagrtchche gytllgdgvs ctpaveypcg kipvlekkna sspqgrivgg kvcpkgecpw
      181 qallrlngal lcggtllaph wvvsaahcld rlrswrnltv vlgehdlsed egheqprqva
      241 qvivpdkyvp grtdhdiall rlrrpavlsd hvvalclpea afsertlarv rfsvvsgwgq
      301 llgrgatale lmavdpqlwq tdepevpscl wplslqahac pmcvncdtdy mpcstp
coagulation factor VII [Tursiops truncatus].
        1 maprlrglal lclllglrgs lvavfvsqeq ahsvlhrprr anwlleelwp gslerecree
       61 fcsfeearei fqskertnqf wisyndgdqc asrpcqnggs cedqlqsylc fcldgfegrn
      121 cetdkksqli cpndnggceq ycrddaeagr tcwchegyal qadgvsctat veypcgkmpv
      181 lqkrndsnpq grivgghvcp kgecpwqaml klngallcgg slldtvwvvs aahcfdrlrs
      241 wrnltvvlge hdlsqdegde qerqvaqvii pdkyvrgktd hdlallrlar pvalgdhvap
      301 lclperafae rtlafvrfsa vsgwgqller gatalrlmav hvprlltqdc rqlsrrrpsg
      361 pvitdnmfca gytdgskdac kgdsggphat hfqgtwyltg vvswgegcaa aghfgvytrv
      421 sqytawlrrl mvspppsggl vrapllp

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

ٱйԺԺʿѡ˳

йԺ½Ժʿѡ˳֤ݡƪһ
ߵӢǱѷĵչ棨ע֣Ĺʽ
Сڰλͼĳ״ͼλֵܴѾ3-5
Ƽûһ涫Ķй̫ˣ֤ѡ
ǹģֱ֤ɣŹԺԸ֤

Yaning Chen, Zhonghe Pang, Xingming Hao, Changchun Xu and Yapeng 
Chen, Periodic changes of stream flow in the last 40 years in Tarim 
River Basin, Xinjiang, China, Hydrol. Process. (2008) DOI: 10.1002/hyp

캣 Ҷ ï ľˮԴ仯ԷԤ⣬
ɺо224ڣ200512

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

Բ֮

ܺĳоŽٴ걨йԺѧԺʿ
֯ҵʿձעһŻ⣬ŽһֱԳй
֮вپڿԱԴ˲ͬΪԲαװ۵
оͽϡԲѵͼϣо̱
һžѧȵλоˮƽӲҪԼ˵ǡйԲʵһ
ˡԳΪԲֻ֮ǹŪ񻰺ͲĻԡ

žԲʷװ1987꣬С87Բʡ֮ƣΪ
ȷ֯ԲͼM81Բʡ˺ϽṹĸĽ
ͼһֱû䣬ֱ2007װ07ԲʡսŽһִ߿4ɫԲʷ
չС߿4ɫԲʣӦͬ;ֵ

ҹйԲαװоرһͣһֱ̱һͽ
ѧȵλ87Բʡܺоְҵ
װо̱һзɹ1986ͨ
ÿˣɫζȲߵ⡣

Ž19849´3530̴ѧ˶ʿоо
ɴ豸1987ϰҵ䵽оġˣʱϿ
ûԲαװ֪ʶܸյоԲαװۺͼ
֡87Բʡо

ŽоԲʷйصĹֻ4棺

11987һżȻῴо͹̱һƵ
ϺƣƷɫζȲߵ⣬ѯʵ¹˾Ⱦ
Ϲ˾ΪṩԲȾʱļӹգ֪øķɫζȣ
쵼빺¹ʽ룬쵼֧½ɹ
ø豸ȻԲͼɫζȣɴȡԲʲ

2ŽΪûɹɻоԺȾܳ
CD01ںCD02ȾϺںӱ齨һʵ鳧
ȾϷʹ豸ȾܳȾϴˮɫټӼ
ӡȾҲŽͨƷһ׬Ǯ

31999оϺ󻯹ѧԺ컪ʦṩѣ
컪оþۺȾϣ2000귢3ƪģɫζȴﲻʹҪ
δʵʹã

4оһλո߹ӽžѧйԲαװĽ
ΪУڹ⹺һЩԲαװ鼮󣬱һԲαװ
2002й֯档

ǣŽԺʿ걨˵Ļѻ

12009ΪԲѵϸ
ʵϸ豸ɸоʴӵ¹ڣзƱΪ֤ٱ
2011Ų˿

220092011Ͼƺϳ֪ʶȨľں;
ȾϣӦȫԲʷϡû˾ٱ⣬1994
һڡȾϹҵ־ϿڻоԺȾܳ
ڡȾͨʡıлָоרΪר
ҲλᣬʸоƵλȾֻ87Բʣδ
07Բʣ

320092011Ͼƺϳ˾۷ӦȾϣʵϸ
оϺУֻ̽оɫζȹδʵʹá

˺ֵ͡͡Į͡ͺͳϵԲѵƣ
ԲƷֵƾŽ޹ء

ԲαװϣŽֻڽ87Բɫζף
񻰺ͻѻһ񻰺ͻѻ˵ԺʿȻΪԺʿ
ͶһƱĵĿľҪʵڣԺʿͶʥһƱʱ
һݡ

ŽԱࡰԲ֮Ļս

̱һ ߹
žѧ 

2013527

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

ٽںûί



ã

 Emory University  University of Louisvilleְڼ䣬
٣7ƪ±ڿ塣¼Ƿз ר
ְڹҽҩѧȥ˻ί80ԪΪ֤Ҿ
Ѳ˷ѣͨίչ ʵǷڻ
ڵҪ¶ˣ

ίĿϢ

81272614/H1615 ƲϷٰϸؼøILKźͨ
·о  ҽҩѧ 

ٵĲֱ뿴
http://retractionwatch.wordpress.com/category/by-author/shou-wei-han-r
etractions/

1. PPAR/ agonist stimulates human lung carcinoma cell growth 
through inhibition of PTEN expression: the involvement of PI3K and NF-
B signals

RETRACTION

The authors request the retraction of the following article 
published in the Am J Physiol: Han S, Ritzenthaler JD, Zheng Y, Roman J. 
PPAR/ agonist stimulates human lung carcinoma cell growth through 
inhibition of PTEN expression: the involvement of PI3K and NF-B 
signals. Am J Physiol Lung Cell and Mol Physiol 294:L1238-L1249, 2008.

The reasons for this request are as follows. Data presented in 
figure 1G were manipulated and duplicated in figure 4C. Images 
presented in figures 1A, B, E, and H were manipulated and represent 
duplications of data presented elsewhere. Also, actin controls for 
figures 6F and 6H and for figures 5A and 5B were duplicated.

An investigation conducted by the University of Louisville 
concluded that the digital manipulations and image duplications were 
performed by the first and corresponding author, ShouWei Han, without 
the knowledge of the other co-authors. ShouWei Han has not responded 
to requests by the journal or the investigators. Therefore, the 
co-authors have requested the retraction of this article and apologize 
to the readers of the journal

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

廪ʦͨԵĺ

ߣɳ

廪ѧѧԺҳ廪Ľ
http://www.tsinghua.edu.cn/publish/env/6422/2011/20110219162722201513606/20110219162722201513606_.html
ٿʦҳ
http://www.bnuedu.org.cn/New.aspx?cid=939Ǳʦڡ
ͬʱֵĹҿƼĿ5֮ࡣƼĹ涨ÿͬʱ
ֺͲĿܳΥͨԵΥϣõ
лѧ˹ͬƣʹлѧ͸ˬ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

йоԺԬءӳϮ

Ԭ    2007ڡ˵ѧ̽⼼ġM T M 
˿ F P G A ܼӹ̼
ӳϮ1999Total dose and SEE of metal-to-metal antifuse FPGA

1999ԭ
Wang J J, Cronquist B, McCollum J, et al. Total dose and SEE of 
metal-to-metal antifuse FPGA[J]. Notes, 1999, 80(100): 120.
2007ӳϮģ
Ԭ, , . MTM ˿ FPGA ܼӹ̼[J]. ˵ѧ
̽⼼, 2007, 27(1): 147-149.

2007ȫУ漰ONO˿ĲԼģԼֻΣʣ
MTM˿Ķȫ1999ԭġ
2007µıMTMҲMTM˵˼ҵĳɹã
ĽıȽϡ

Ȼ2007ο׵ڶ1999£д󲿷
ƪֱӷԭģͼʹһģ˽ΪȻڳϮ

2007µĵһڶߵλֱǣ
йоԺӹо,Ĵ,621900;ѧϢѧԺ,ɶ,610039
йоԺӹо,Ĵ,621900
ѧϢѧԺ,ɶ,610039

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

մѧѧѧѧԺڡѵմѧϢϵĵطһĵļ

˿վ2013519տˡ׫дġѵ
մѧϢϵĵط𣿡һģ߲δᵽ
ѧ밲մѧѧѧѧԺйأǵĸ߶ӣ
ΪʵȫӰ˰մѧԺԺΪ


һѡƸ¡УΪ߽ѧ
ˮƽӿѧƽ裬˲ƶһϵļ
ȡЧʦʶṹõŻֹ2010ףרν
ʦовʿѧλռ25.99%ƽ48.8꣬ռʦ16.03%
磬ʦʶˮƽҡǧ˼ƻѡߡҽܳѧ
ߡҽѧʦ߾ʵͻơУ˲
ҲǷֲģ˲żƻʦչƻѡ
ƸֻǸ߲˲ϵͳеһߣԵǺԳ
߲˲ţĿУԺݺͼݵĸ߶˲ţ
ȡֻɽһǣȡ壬ƫȫߵƶ
عΪѧУҪ쵼ΪıΪʶǲʵʵġ

ѵһĶУ쵼á裬Ǽ䲻ε
ͷ̰ΪˡκȫͨϷ;
ԷӳӦͨ˸񡢰ܻķǷֶйԼ
Ϊ빹гĴ󱳾ҲΥҹ
ɹ涨ҪеӦķΡ

ᵽմѧ´쵼ԺΩǴӵäߡ
ΪĽϵģҲʵϵġУԺ˲
´ָЭ£ȡ˽ϴչ´ָ
ְܲŵĻǷֲġ߶ѧУдԺƫ
ƫΪֲεǲ׵ģҲǼġ

һ¶ʮ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

ФԳƵĳɹˮ

ߣʸ

ժҪФܲɷʱơ人Э200Ч72%Ф
ĺФĿгɹΪ87%ؼݺĿҪ
ˮӦФ̫ࡢǰĻˡФֳơԼǲ
вɹġȻ人ѻҲˣЭĸ
ӶЧΪ˥͸

Фܡɷáɷʱƣ人Э200Ч72%
ѵĲˡʵФǰƵĳɹʱ߶ˡ

Ф2006ĳƣ2004ףԺעĻΪ人Эҽ
Ժ92߷Ի԰׵ļ˲ˣ-񾭷
ƣ81һð׹ܿơעո
Ϊ200510£õһݾݳ20057µĻժҪ
Ѷ110輹Ĥͯȫ˴һóɹΪ87%
20ĳɹֻ85%

ҲBeaumontҽԺNIHФĿУΪ
ĿҪݣйҽעָФ棬92˻
88%񾭴һڻð׿ƹܣ110Ѷͯһ
ɹΪ87%ҽԺơФ˽90%ĳɹʡ

8ȥˣһؼĳɹôˮˣӦФ̫ࡢ
ǰĻ˰ɣʵڰѳɹһˮʲôФ
֣Դʵʩ8£걨Ժʿ֤лѳơ8
6085ĻߴСѻָ

ݵ걨֯Ȩר֤ФʱЭҽԺҲЯ
İμӣר϶ФȫЧȱѭ֤ҽѧ֤ݡ
רǲǴЭͲзè壿

ФܲɷʱֳƣԼǲвɹġФ
ȻԲá

ڴһ£ФĻ߼ǲܲ人ѻ
XXXXɣݻͶ߲ϣ20021³人Э͡һ
ĸӶûЧеĶΪ˥͸Фǲ
ǰ4߶87%ĳɹʣ72%Чʣˣ

ο

1. 20130524Фܡɷáɷ

http://news.ifeng.com/mainland/detail_2013_05/24/25664703_1.shtml
Ф2006굽2012ܹ꣬2000ƽЧʴΪ
85%人Э200Ч72%ѵĲˡԼǲ
вɹġ

2. Ф2006һݾݳ20057µĻժҪ

By the end of 2004, a total of 92 SCI patients with hyper reflexic 
or acontractile bladder in our hospital have been treated with the 
somatic and autonomic reflex arc procedure and 81 of them regained 
bladder control one year postoperatively.

Up to date, we have performed the procedure for bladder and bowel 
control safely on 110 children with spina bifida [25]. The rate of 
success at the one year follow-up is 87%, compared to the 85% for the 
first 20 cases reported.

[25] Xiao CG. A somatic-autonomic reflex pathway procedure for 
neurogenic bladder and bowel: results on 92 patients
with SCI and 110 children with spina bifida. . In: Proceedings of 
the International Conference of Urology; Shanghai, July 2C4, Shanghai, 
China; 2005.

3. BeaumontҽԺNIHФĿ

The Chinese physician had reported that of 92 SCI patients, 88% 
regained bladder control within one year after the nerve rerouting 
surgery and in 110 children with spina bifida, the reported success 
was 87% at one year.

4. 20021³人Эѻ

http://blog.sina.com.cn/s/blog_66a1fc170100tyi5.html
һԺ6人ĵһֻĸ
2002124ҶʱȥҽФźһλ
ʿһֱȺФʱ׿ڶ˵ǳ˳
һĸӶûЧXXX

http://blog.sina.com.cn/s/blog_66a1fc170100u5qf.html
20021ФġФ2002굽ڴ
Сûʲôƣ˫ȫڷءֵͬҽԺ˶
ҰѸκá

http://tech.sina.com.cn/i/2010-09-23/16184686239.shtml
Ůʿס~ڣŮ14꣬2002һФΪŮ
һˣֶˣֻö
ûܳɹ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

ЩΪԭױƷվ̨йڡר˴

йӪѧ³йԤӪʳƷȫӪ
ѧѧԺ
йʳƷ͹ҵоԺԺľ
йʳƷѧѧ˶ӪʳƷֻ³ѧʿʦ
пԺо΢̼оιന
пԺооԱű
ѧӪѧʿӪѧӪ̷ֻίԱٷ
ӪѧʿйʳƷ͹ҵоԺоַ
ѧѧԺӪʳƷѧϵ
ٿѧίԱίԱйӪѧԱӪ硱
ҽԺӪӪʦӪʦЭ¹һӪʦһ

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

ҽ롰ֵֻ֧֮⡰о

ߣԶҽҩ

κһСѧʲô˼ӦǸ
⡣ǣҽǸ⡣

Ϊ漰Ƶھ صۡǣߣ֮Ҳ
ɡ ۡ˵Ĳ񡣡ʾһеĺ塣
˼˵อоҪλָ߼񾭻ܻ
ͬһУǸģƵھ--⾫΢ƪص
ҲҲ߹֮ҲΪ顣

ɴ˿ɼڴͳҽһеģӲ
ѡ񶨡,ЩǷ񶨻ƵھڸɲݵĻ
ǰȻҽɱҲǴòɿû˻ɵġ
һЩʿҽйЩҽҲл˽ҽĽѧ
ҽ۵Ӱ죬һЩҽΪԪ֮18601933
͵ġԹĹ۵㡣

һΣйֵҽϡҩҩ֮棬
ʯ֮ԣҩ˾ƥֲáʯ֮󣬶֮
ᡣ˾ƥζƴʹ֮ ɱɢʯΪ
ʵ֮Ҳ鷢ȣ죬Ȫͷ˾ƥ֣η
ȣ԰ƥִʯ෢ҩ򾲼ҩ𡢵̵
֮Ʒ飻ţ廯ػˮȩ԰֮ǵ
ʶһ۾ΪʲôҽӱԵĺٻ

ڣȫռ˽˻֪
ҪٵĹܡˣҲҽǣҪҪټ
ЩҽرйɫҽҽŽִܸѧƵ


ҽѧḱ᳤鳤ʿ2002328ڡйҽ
ҩΪȷ ҽչͻƵ㡷£ڻ
ˡƵھҽҹġԹܵĻϣҪ
Ϊ۵Ĺ۵㣬Ϊȷ ҽҩ
ʵִչͻƵ㡱1£ʿڡϺҽҩ־
Ϊҽѧ͡ ʶһģϵͳ
۽衢оȷˡ˵ȷ
ҽҩѧʵִչһϵ ͳ̡ǿ
һҽҩѧִչаѴͳԵҷ˼
еıȻѡ

ȻôһСҲҽвͬ⣬ҽ̩ξ
һ20023£νڡҽ־ Ϊ
Ŀѧԡ£ԡ۵Ĺ۵˷ҽҩѧ
Ƽϣҽѧʱ䡯ʽķԾķչνǿ
޳ҽҪϴ·չԴΪںţҽѧ֮


:ʵǻҽ
ѧ˵Ŀѧԡν󡱣ġΡƢΡĺ
ҽѧ˵幦ܼԹɵϵͳһѧ˵...
ҽĽѧ⣬ֻõϵͳۡۡϢ... 

ԡȡһҽѧĴԵĹܣҽ
ѧȡʹ̾ĳɹšòŻȥо
оҲѳѧߡᳫ޷ǽҽѧԸҽѧҪ
۽Ӻ֣ʲô滮ͼ ʲô취ʹ
ҽ֮ϵͳںϣһǸñȥˡд̫
ˡñȰҽѧõһЩʯ߸ȥһ
ɫ֧ܣһִҽѧŪˡʵ̫Σ!
㣬ҽΣ!

ֵŵǰǣǹ󽢼齭ϣ
ôоҲѳˣչƵķͰ̾ܵĿɡ.  

Ρ--֮ûʲô˵μλҽ
飬ҽӣblablaȻ󣬵Ī973ƻ
ҽۻоרΪϯרңеˡҽ봴
оǰ꾭1700Ԫ֪жͶ֤

===============================================

ѧһ£ֲܷٸֵ֧ĸ⡰
о

ۺʶҽԲ
ߣ ʷǷ 
ʱҽҩ CA CSCD 20127
𣺹ȻѧĿ(No.81173144; 㶫У괴
˲ƻĿ(繤̣(No.2011-LYM11043

ժҪĿ϶ԣۣΪָĴͳҽԲѧ˵Ļ
ʷ,ͬʱ̽ҽԲص㡢֤˼·˼,
ΪָµҽԲѧǶԴͳ...

ҽѧġĸ
ߣ Ų ׾ 
йҽҽѧ־ CA CSCD 20128
𣺿ƼԹר-ҽҽѧѧʹ淶ƶ
(2008FY230300
ժҪҽѧԣ㣢Ϊָ˼,
ģҽѧҪĸ֮һУģĸ
лͳĻ,Դִҽѧ...

֮̽ҽѧԵĹ
ߣ ÷
лҽҩ־ CA CSCD 201110
Ͼҽҩѧҽר(No.08XJC01
ժҪˣ룢,Ϊ
ǽҽ֮,˵ࡢġ֮ϵһѧ˵,
ҽԲƾҪָá...

ԡġʶ
ߣӱ 
йҽҽѧ־ CA CSCD 20104
𣺿Ƽҵѡ(ZZ2006003ZZ2006016
ժҪ.ۡԻ֮Ѫ.صۡԻ
,֮,ɡĵҪѪҽѧо
ĲϽ,ڣģĹܵʶҲӷ...

΢
ߣ Ω 
йҽ֢ 20111
Ͼҽҩѧר(08XJC01
ժҪҽѧһҪۡĴӴͳʶִҽѧ
Ϊ,ǿѧ,۾ص,Ӧоʶ,
Ϊཡ

İҩƹĲȶĽʹļȱѪЧ۲
ߣ Ȫ Ҧƽ  췼 Ƽ
ҽѪܲ־ 200810
ΪɶҽҩѧУ(No.ZRTB2007024
ժҪĿĹ۲İҩƹĲȶĽʹļȱѪٴ
Чһ̽İҩļȱѪĻơϲѡ׼60
ĲȶĽʹֳ飬...

ķѧ˼
ߣӱ
ʱҽҩ CA CSCD 20089
ϺнίлĿ(No.06CS052
ժҪ׿֤ӷѧǶ̽ˡ
ָ֮ġӦΪ֮ģһʶĻȡڹŴѧ
ۡȡ˼άӰ£ѧΪݣ...

ڡ뷴˼
ߣЧϼ 
ҽҩ CA 20065
𣺽ߵѧУʿѧƵרлĿ(20050441006.
ժҪγɣ֮֮̾ҵ
۶ҽѧУอġʸ񡱶߱Ҳ͸̸
Ĺܸˣʡ...

֪ĺĬоеʾĿ
ߣٻ 2005-9-22
Դлִٴҽѧ־ 
ժҪ: Ŀ:ҡ塱Ŀ96-906-09-01ժҪ Ŀ
 ֤ܵҪúִҽѧе֪
ܣ֪ܵϰ ڸƸò֪ܷ
ȷеЧ ֤ʵڸ֪ٴָ塣ؼ
   ֪......

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

Ĳݹȥ30ǧ ޶Ч

»籱525յ ڡԴࡢܾĲݱ
һ·ƽȻгķ׷
ɵҲԽԽ࣬ҽѧͿѧרΪĲݲ棬
ûжЧ

ȣʲôΪ桢Ϊݣֲһ壬˵
ͨһ㣬ǳϳһѧѧѧԺʿ󡢿
˵

˵ĲǾֲһǳ
׳棬һֳļӽѲڵ棬׳
볱ʪ㡣һϮ׳棬׳
ڶ괺죬˿ʼʱ棬һС
ݡ׳˿ͬһġĲݡ

ȥ30ǧ

ڹȥ30Ĳݵļ۸ǧһλڴչ
м˵70ຣһչ۽ʮԪûҪ
ԡ90ڣնۼǵ2000Ԫһڣ
ۼ۳30Ԫһ

ݴ³˽ܣĲ۵ıǳ2003ǵڼ䡣
꣬ÿݼ۸ǵ1.6Ԫʱ˳ƣ
ãܰΰٲһҹˡݡ

ǵȻȥǳݵ񻰲û֮ʧÿ50
ٶǡ2007꣬ļ۸һͻ20Ԫһ2008ݻ
һ·

Ӧ

Ŀǰû㹻ѧ֤ݱݶԿáжʵƳ
ݶԿưϸһЧٴ黹ʮǧҴҵʮ
ľ۲죬ûзⷽĹЧ侯ҽԺƿΡ
μС˵֤ЧֻһַǴ˫äٴ
飬Ĳûб֤

֪ҷ׫ݵĳ̼Ըԭ
ٵԣ񻯣ûжֵôļֵע⵽
Ĳڷǵ֮ͻȻġʱҪǶԷǵĿ־壬
ǿߵͷʵϲǰο

гķ201012·ݣʼַܾˡڶĲݲ
ΪͨʳƷԭϵ֪ͨϽʹöĲΪʳƷԭͨʳƷ
չܾҲعˡشƶĲݽҡ

ΪĲݵķ̬вҲƭϰջ˺ܶԩ
Ǯɴ˽ҵ񻰣ӦñơĲݣҩ񻰣
ǿѧЦ˵

(XYS20130531)

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

һΪ˰޷˿վĹ˽˿վĶ̬ؿ
˿ʼбxys@yahoogroups.com

ʼбÿ췢һ˿վ¸µϣÿµ׷һÿ
Ŀ¼ʼбĶμ롰˿֮ѡ
ʼбxys_friends@yahoogroups.com

ù䶩ġù䣬ܿ޷յ
Ƽ䣺yahoo.com, hotmail.com, gmail.com

ġ˿ʼбĵ䷢һհż

xys-subscribe@yahoogroups.com 

塢ͣ˿ʼбͣ䷢һհż

xys-unsubscribe@yahoogroups.com 

Ͷxinyusi@yahoo.comôıļͶ塣

˿(www.xys.org)(xys7.dxiong.com)(xys.ebookdiy.com)(xys2.dropin.org)

